Tag GLP-1

Retatrutide

Triple Agonist Peptide Overview Mechanism Adverse effects Protocols Reconstitutions FAQ is an experimental drug for obesity developed by the American pharmaceutical company Eli Lilly and Company. It is a triple hormone receptor agonist on the GLP-1, GIP, and glucagon receptors.…